Related Experiment Video
Updated: Oct 13, 2025

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Long COVID and COVID-19-associated cystitis (CAC)
Laura E Lamb1,2, Ryan Timar3, Melissa Wills3
1Department of Urology, Beaumont Health System, Royal Oak, MI, USA.
Long COVID can cause new or worsening overactive bladder (OAB) symptoms, termed COVID-19-associated cystitis (CAC). This study identified significant OAB symptom and quality-of-life declines in patients months after COVID-19 recovery.
Area of Science:
- Urology
- Infectious Diseases
- Public Health
Background:
- Limited research exists on genitourinary symptoms following COVID-19, particularly in the context of Long COVID.
- Overactive bladder (OAB) symptoms, including urinary urgency and frequency, can significantly impact quality of life.
Purpose of the Study:
- To identify recovered COVID-19 patients experiencing new or worsening overactive bladder symptoms.
- To characterize these symptoms as COVID-19-associated cystitis (CAC).
Main Methods:
- Utilized the American Urological Association Overactive Bladder (OAB) Assessment Tool for screening.
- Assessed 350 COVID-19 recovered patients 10-14 weeks post-discharge.
- Collected data on urinary symptom and quality-of-life scores.
Main Results:
- Identified 350 patients with de novo or worsening OAB symptoms post-COVID-19.
- Median OAB symptom score increased from 8 pre-COVID-19 to 19 post-COVID-19.
- Median quality-of-life scores also indicated a significant decline.
Conclusions:
- Survey results indicate new or worsening OAB symptoms in patients months after COVID-19 hospitalization.
- Further research is needed to understand the pathophysiology of OAB in Long COVID.
- This understanding will aid urologists in timely and appropriate patient treatment.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Urinary Tract Infection II: Pathophysiology
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urologic Endoscopic Procedure: Cystoscopic Examination

